Glucophage Sr
In brief
- In our pharmacy you can buy glucophage sr without a prescription, with delivery in 5–14 days throughout the United Kingdom and discreet packaging; note that in many countries the product is officially classified as prescription-only (Rx).
- Glucophage SR (metformin hydrochloride) is used to treat type 2 diabetes; it is a biguanide that lowers blood glucose by reducing hepatic gluconeogenesis, improving peripheral insulin sensitivity and decreasing intestinal glucose absorption.
- The usual dose starts at 500 mg once daily with the evening meal, titrating by 500 mg weekly as tolerated; typical maintenance is 1,500–2,000 mg/day (some brands allow up to 2,500 mg/day under supervision) with a maximum per product label.
- Form of administration: oral extended‑release tablets (commonly 500 mg, 750 mg or 1,000 mg) taken once daily with food.
- Onset time: blood‑glucose lowering begins within about 48–72 hours, though symptomatic and full glycaemic effects (HbA1c reduction) are usually seen over weeks to months.
- Duration of action: the sustained‑release formulation is designed for once‑daily dosing and provides approximately 24 hours of glycaemic control.
- Alcohol warning: avoid excessive alcohol intake and binge drinking as alcohol increases the risk of lactic acidosis when taking metformin; use caution with alcohol if you have liver disease or other risk factors.
- The most common side effect is gastrointestinal upset — nausea, diarrhoea, abdominal pain and flatulence — which is usually transient and improves with slow dose titration; long‑term use can rarely cause vitamin B12 deficiency and very rarely lactic acidosis.
- Would you like to try glucophage sr without a prescription?
Market Realities & Patient Experiences (First Impressions, Adherence, Cost Pressures)
Basic Glucophage Sr Information
- INN (International Nonproprietary Name): Metformin hydrochloride (Metforminum hydrochloridum).
- Brand Names Available In United Kingdom: Glucophage SR / Glucophage XR (500 mg, 750 mg extended‑release tablets) and other metformin SR generics as listed regionally.
- ATC Code: A10BA02 — Metformin; classified under A10B (Blood glucose lowering drugs, excluding insulins), A10BA (Biguanides).
- Forms & Dosages: Extended‑release tablets 500 mg, 750 mg and 1000 mg; oral, once daily.
- Manufacturers In United Kingdom: Not specified; regional suppliers and manufacturers include Sanofi, Teva, STADA, Zentiva, Medochemie and global manufacturers such as Sun Pharma and Cipla.
- Registration Status In United Kingdom: Not specified; Glucophage SR and metformin ER formulations have EMA/local registrations in the EU and are prescription‑only in major markets.
- OTC / Rx Classification: Prescription Medicine (Rx only) in all major markets.
Are other patients finding Glucophage SR easier to live with than immediate‑release metformin?
Many people report once‑daily dosing and fewer peak gastrointestinal events as the main reasons they prefer Glucophage SR.
Cost sensitivity is common, and patients ask whether to get an NHS prescription or to buy privately or online.
Demand through online pharmacies is growing, but prices and supply reliability vary across UK regions.
Patients in Scotland, Wales and Northern Ireland benefit from free prescriptions, which affects purchasing choices.
Common complaints include initial GI upset, confusion between SR, XR and IR formulations, and questions about renal checks before starting.
Trust in pharmacist counselling remains high, with chains such as Boots and LloydsPharmacy frequently named in patient feedback.
Users also voice safety concerns around long‑term vitamin B12 deficiency and the very rare risk of lactic acidosis.
Pharmacist reassurance and clear monitoring plans reduce anxiety and improve adherence in many patients.
Quick Visual Block: anonymised patient quotes and top FAQs help new patients see real experiences and expected outcomes.
- Top 5 Patient Priorities: tolerability, dosing frequency, cost, supply reliability, monitoring.
Product Snapshot — What Is Glucophage SR?
Active Ingredient And Classification
What exactly is inside a Glucophage SR tablet?
Glucophage SR contains the International Nonproprietary Name (INN) metformin hydrochloride (Metforminum hydrochloridum) as its active ingredient.
It belongs to the biguanide class and carries the ATC code A10BA02 for metformin.
Formulation And Strengths Available
How is the sustained‑release formulation presented to the patient at a glance?
| Specification | Details |
|---|---|
| INN | Metformin hydrochloride (Metforminum hydrochloridum). |
| Strengths | 500 mg, 750 mg, 1000 mg extended‑release tablets. |
| Dosing Frequency | Once daily. |
| Prescription Status | Prescription only (Rx only). |
| Indications | Glycaemic control in type 2 diabetes in adults. |
| Regulatory Notes | Available as branded SR/XR and as generics; packaging varies by market. |
Brand naming varies internationally — Glucophage SR or Glucophage XR, and competitor ER brands include Fortamet and Glumetza.
Packaging examples show blister packs of 30, 60 or 120 SR film‑coated tablets in some countries.
Indications And When Clinicians Prescribe Glucophage SR
Primary Indication: Type 2 Diabetes (Adult)
When would a GP or specialist choose Glucophage SR for a patient?
Glucophage SR is primarily indicated for glycaemic control in adults with type 2 diabetes, usually as first‑line therapy alongside lifestyle measures.
Clinicians often start metformin and consider the SR form when once‑daily dosing is preferred to boost adherence or when GI sensitivity to immediate‑release metformin is an issue.
Initiation is commonly managed in primary care, with titration to effective dose during follow‑up appointments.
Off‑Label And Combination Use
Can Glucophage SR be combined with other glucose‑lowering agents?
Off‑label or adjunct uses include combination therapy with SGLT2 inhibitors or DPP‑4 inhibitors as part of early combination strategies recommended by international guidelines.
Metformin SR is often continued with other agents to maintain glycaemic control and for its favourable weight and cardiovascular profile.
| Combination Agent | Rationale |
|---|---|
| SGLT2 Inhibitors (e.g., dapagliflozin) | Additional glycaemic control and cardiovascular/renal benefits in selected patients. |
| DPP‑4 Inhibitors (e.g., sitagliptin) | Well tolerated add‑on with low hypoglycaemia risk. |
| Sulfonylureas / Insulin | Used when oral agents alone are insufficient; monitor for hypoglycaemia when combined. |
Decision flowchart: choose SR over IR when adherence or GI tolerability is a concern and when once‑daily dosing simplifies the regimen.
Dosage, Titration And How To Take Glucophage SR
Starting Dose And Titration Schedule
How should a patient start Glucophage SR to limit side effects?
Begin with 500 mg once daily with the evening meal and increase by 500 mg each week as tolerated until targets are met.
The commonly used maximum total daily dose is around 2000 mg, while some brands permit up to 2500 mg per product labelling.
Missed Dose, Switching From IR, And Special Population Notes
What should a patient do if they miss a dose or switch from immediate‑release therapy?
If a dose is missed, take it as soon as remembered unless it is near the time for the next dose, and do not double up.
When switching from IR to SR, check total daily dose equivalence, advise slow titration and watch for GI symptoms for 2–4 weeks.
Renal function should be checked before initiation and during titration, especially in older patients.
| Parameter | Recommendation |
|---|---|
| Starting Dose | 500 mg once daily with evening meal. |
| Titration Increment | Increase by 500 mg each week as tolerated. |
| Target Dose | Individualised to glycaemic response; common total ≈ 2000 mg/day. |
| Maximum | Commonly 2000 mg/day; some brands up to 2500 mg/day. |
- Pharmacy Counselling Checklist: confirm prescription, advise evening dosing, explain missed dose rule, warn about GI symptoms and arrange renal check.
Contraindications, Cautions And Special Populations
Absolute Contraindications
Who must not take Glucophage SR?
Absolute contraindications include severe renal impairment with eGFR less than 30 mL/min/1.73 m² and known hypersensitivity to metformin or excipients.
Acute or chronic metabolic acidosis, including diabetic ketoacidosis, and conditions associated with tissue hypoxia are also contraindications.
Cautions: Renal, Hepatic, Elderly, Pregnancy/Lactation
Which patients need closer review before prescribing?
Do not initiate metformin SR if eGFR is between 30 and 45 mL/min/1.73 m² without careful review, and reassess frequently if renal function declines.
Hepatic impairment increases the risk of lactic acidosis and should generally preclude use.
Children under 18 are not generally indicated for SR formulations due to limited data, and older adults require cautious titration and renal monitoring.
- eGFR <30
- Absolute contraindication.
- eGFR 30–45
- Do not initiate without specialist review; monitor closely if already on therapy.
- Age >80
- Only use if renal function is normal and under close monitoring.
- Quick‑check For Pharmacists: confirm recent eGFR, ask about heart or respiratory failure, review alcohol use and planned imaging with contrast.
Side Effects, Monitoring And Long‑Term Safety
Common Transient Effects And How To Mitigate
What side effects are patients most likely to notice at the start?
Gastrointestinal effects such as nausea, diarrhoea, abdominal pain and flatulence are the most common and usually improve with slow titration.
Using the evening meal and switching to SR can reduce peak GI symptoms compared with immediate‑release metformin.
Serious But Rare Risks And Monitoring Schedule
What rare risks require vigilance and ongoing monitoring?
Very rare but serious is lactic acidosis, which presents with unexplained tiredness, myalgia, abdominal pain and rapid breathing and requires immediate medical attention.
Long‑term use can be associated with vitamin B12 deficiency, so check B12 in symptomatic patients or after prolonged therapy.
| Common Side Effect | Action |
|---|---|
| Nausea / Diarrhoea | Slow titration, take with food, consider changing to SR if on IR. |
| Flatulence | Dietary advice and time; often improves with continued use. |
| B12 Deficiency | Check B12 if symptomatic and consider supplementation if low. |
| Lactic Acidosis | Stop drug and seek emergency help if symptoms of malaise, myalgia or rapid breathing occur. |
- Monitoring Checklist: baseline renal function and periodic eGFR checks, B12 where indicated, review of GI tolerability and symptoms at follow‑up.
Drug Interactions And Clinical Precautions
Common Interacting Medicines (E.g., Iodinated Contrast, Cimetidine)
Which medicines require extra care when patients take Glucophage SR?
Iodinated contrast media increase the risk of renal injury and lactic acidosis, and local protocols typically advise withholding metformin at the time of contrast and reassessing renal function before restarting.
Cationic drugs such as cimetidine can reduce metformin elimination and may require monitoring or dose adjustment.
Combining metformin with insulin or sulfonylureas can increase hypoglycaemia risk, so counsel patients on recognising low blood glucose symptoms.
Lifestyle Interactions (Alcohol, Dehydration)
What lifestyle factors raise safety concerns?
Excessive alcohol increases the risk of lactic acidosis and should be avoided or minimised while on metformin.
Periods of dehydration, acute illness or vomiting can reduce renal perfusion and mandate temporary discontinuation until recovery.
| Interacting Agent | Clinical Effect | Pharmacy Action |
|---|---|---|
| Iodinated Contrast | Risk of renal impairment and lactic acidosis. | Advise withholding per local protocol and check eGFR before restarting. |
| Cimetidine | May reduce metformin clearance. | Review concurrent therapy and monitor renal function. |
| Alcohol | Increases lactic acidosis risk. | Advise moderation and provide written guidance. |
- Pharmacy Action Checklist: review upcoming imaging or travel, advise sick day rules, and ensure clear documentation of temporary stoppage and re‑start plan.
SR Vs XR Vs IR And Competitor Positioning
Pharmacokinetic Differences And Clinical Relevance
How do sustained‑release and immediate‑release metformin differ in everyday terms?
SR and XR describe extended‑release technologies that spread metformin absorption to reduce peak plasma levels and lower gastrointestinal adverse events.
IR formulations usually require multiple daily doses and can be associated with greater GI upset in some patients.
Competitor Products And Cost/Availability Comparisons
Which brands and generics might a patient see on the shelf or online?
Competitor ER brands include Fortamet and Glumetza, and generics from Teva, STADA and Zentiva offer cost alternatives with similar ER technology.
| Formulation | Tolerability | Dosing Frequency | Price Snapshot |
|---|---|---|---|
| SR/XR | Generally fewer peak GI events. | Once daily. | Varies between UK chains and online; check live prices. |
| IR | Potentially more GI symptoms for some patients. | Multiple daily doses. | Often cheaper per tablet but consider adherence cost. |
Pharmacy practice note: always verify a true ER formulation when switching to avoid accidental duplication of dose or altered pharmacokinetics.
Packaging, Authenticity, And Manufacturers
How To Verify Packaging And Batch/Expiry Data
What should customers check when they receive a pack of Glucophage SR?
Verify the batch number, expiry date, leaflet language, tamper seals and any MHRA identifiers or CE markings where present.
Packaging appearance can vary by manufacturer and market, so look for consistent labelling and intact blister packs.
Major Manufacturers And Country Variations
Who makes SR metformin globally and how does packaging differ?
Prominent manufacturers include Sanofi, Teva, STADA, Zentiva, Sun Pharma and Cipla, and packaging is adapted to local regulatory requirements.
For example, ANMDMR lists Glucophage SR in Romania in blister packs of 30, 60 or 120 film‑coated SR tablets (500 mg, 750 mg).
- Checklist For Suspicious Packaging: missing leaflet, mismatched batch numbers, poor print quality — report via Yellow Card or to the pharmacy.
Regulatory Status, Legal Classification And Prescribing In The UK
Prescription‑Only Status And MHRA Considerations
How is Glucophage SR regulated in the UK?
Metformin extended‑release formulations are prescription‑only medicines and fall under MHRA regulation in the United Kingdom.
Local prescribing and monitoring should follow MHRA guidance and NHS formulary recommendations.
NHS Formularies And Electronic Prescriptions
What documents should patients bring when collecting a supply?
The NHS prescription pathway supports GP or specialist initiation, repeat dispensing and electronic prescriptions (EPS) for community pharmacy collection.
Patients should present a valid prescription and, where requested for private supply, identity documentation as per the pharmacy policy.
- Documentation To Bring: valid prescription, any GP monitoring letters, and contact details for queries.
How To Buy Glucophage SR In The UK: NHS, Private, And Online Options
Pharmacy Chains Vs Independent Pharmacies
Where can patients obtain their metformin SR in the UK?
NHS repeat prescriptions are typically managed through GP surgeries and dispensed by community pharmacies including Boots, LloydsPharmacy and independent chemists.
Prescription charges apply in England but not in Scotland, Wales and Northern Ireland, which affects private purchase decisions.
Online Pharmacies, E‑Prescriptions And Courier Delivery
Is it safe to order Glucophage SR online?
Choose an MHRA‑registered online pharmacy that requires a valid prescription and provides pharmacist contact details and clear delivery policies.
Tablets do not require cold‑chain transport and should be dispatched in original packaging to preserve authenticity.
| Route | Cost | Convenience | Counselling Availability |
|---|---|---|---|
| NHS | Prescription charge in England; free in devolved nations for eligible patients. | Local collection; repeat dispensing available. | In‑person pharmacist counselling available. |
| Private | Variable; pay per prescription. | Faster access for some patients. | Pharmacist counselling usually available. |
| Online | Varies; compare regulated sites. | Home delivery; discreet packaging. | Remote pharmacist support required by law on regulated sites. |
In our online pharmacy, glucophage sr is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.
- Ordering Checklist: valid prescription where required, check MHRA registration, verify delivery and returns policy and confirm pharmacist contact.
Storage, Transport And Disposal Instructions
Storage At Home And During Travel
How should patients store Glucophage SR at home and while travelling?
Store tablets at room temperature between 15–30°C in the original packaging, protected from moisture and heat.
Carry medication in its labelled blister pack with a copy of the prescription or GP letter when travelling.
Safe Disposal And Pharmacy Returns
What is the correct way to dispose of leftover or expired tablets?
Return unused or expired medicines to a community pharmacy take‑back scheme and do not flush tablets down the toilet.
- Travel Pack Checklist: medicine in original blister, copy of prescription, small hard storage case and contact details for pharmacy.
Managing Special Clinical Scenarios (Renal Impairment, Perioperative, Contrast Imaging)
Renal Impairment Management And Dosing Thresholds
How should pharmacists advise patients with reduced renal function?
Metformin SR is contraindicated if eGFR is under 30 mL/min/1.73 m² and should not be initiated if eGFR is 30–45 without careful review.
Monitor eGFR more frequently in patients with declining renal function and consider dose reduction or stopping if thresholds are crossed.
Perioperative/Sick Day Rules And Contrast Media Guidance
What steps are required around surgery, acute illness or contrast imaging?
Advise patients to temporarily stop metformin during significant illness, dehydration or before major surgery until clinically stable and renal function reassessed.
For iodinated contrast procedures, follow local radiology and MHRA guidance to withhold metformin at the time of contrast and check renal function before recommencing.
- Pharmacist Protocol: check scheduled imaging or surgery dates, notify prescriber if stopping is needed, document advice and arrange follow‑up eGFR check.
Combination Therapy, Switching Strategies And Formulary Notes
Typical Add‑On Agents And Rationale
Which agents are commonly added when metformin alone is insufficient?
Common add‑ons include SGLT2 inhibitors and DPP‑4 inhibitors, chosen for glycaemic efficacy and patient comorbidities.
Metformin is often continued for its weight‑neutral and potential cardiometabolic benefits where tolerated.
Switching From IR To SR And Interchange Considerations
How should a patient be counselled when switching formulations?
Ensure total daily dose equivalence, counsel on gradual titration to reduce GI effects, and verify formulation strength to avoid accidental duplication.
| Scenario | Practical Advice |
|---|---|
| Switch IR → SR | Match total daily dose, start with SR 500 mg once daily if initiating and titrate as needed. |
| Add SGLT2 | Monitor renal function and advise on genital infection risk and blood glucose monitoring. |
Patient Counselling Script: explain the reason for switching, how to take the new tablet, what side effects to expect and when to contact the GP.
Product Page Elements, SEO, FAQs And Compliance Blocks
Mandatory Legal Text And Prescribing Disclaimers
What must appear on a compliant product page for Glucophage SR?
Include a clear product title, INN Metformin hydrochloride, strengths, prescription‑only status and the MHRA or local regulatory disclaimers.
State: “Prescription only — supply only against a valid prescription” and provide a Yellow Card reporting link.
Recommended Blocks: FAQs, Dosage Table, Comparison, Reviews
Which content blocks improve user experience and compliance?
Prominent dosage tables, contraindication quick lists, common side effects tables, monitoring checklists and clinician contact information are recommended.
- Page Components: FAQs addressing how to take Glucophage SR, switching from IR, monitoring needs and delivery expectations.
Ensure SEO uses natural language around glucophage sr, metformin SR tablet and metformin prolonged release without compromising clinical accuracy.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 5‑7 days |
| Manchester | North West | 5‑7 days |
| Birmingham | West Midlands | 5‑7 days |
| Glasgow | Scotland | 5‑7 days |
| Edinburgh | Scotland | 5‑7 days |
| Cardiff | Wales | 5‑7 days |
| Belfast | Northern Ireland | 5‑7 days |
| Leeds | Yorkshire and The Humber | 5‑9 days |
| Bristol | South West | 5‑9 days |
| Newcastle | North East | 5‑9 days |
| Liverpool | North West | 5‑9 days |
| Sheffield | South Yorkshire | 5‑9 days |
| Aberdeen | Scotland | 5‑9 days |
Frequently Asked Questions
Can I take Glucophage SR with food?
Yes, take with the evening meal to reduce gastrointestinal side effects.
Do I need regular blood tests on Glucophage SR?
Baseline and periodic renal checks are required, with B12 checked if symptomatic or after long‑term use.
Is Glucophage SR safer than IR for stomach upset?
SR aims to reduce peak GI effects and can be better tolerated for some patients.
How soon will blood glucose improve after starting?
Glycaemic response varies; clinicians titrate dose weekly from 500 mg once daily and assess response in follow‑up.
Reporting Issues And Further Support
What should patients do if they suspect a problem with their medicine?
Report suspected adverse reactions via the Yellow Card scheme and contact the dispensing pharmacist or prescriber for urgent advice.
Pharmacies should document product batch and supplier details when reporting supply or safety concerns.
Final Notes For Pharmacists And Purchasers
Keep prescribing and counselling consistent with MHRA and local formulary guidance and verify eGFR before initiation.
Ensure that patient leaflets and monitoring plans are provided at the point of dispensing or delivery.
Encourage patients to report side effects and to bring any leftover tablets to the pharmacy for safe disposal.
